3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
72
Lymphoma, Follicular
23
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, Mantle-Cell
12
Lymphoma
10
Recurrence
8
Neoplasms, Plasma Cell
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, Non-Hodgkin
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Smoldering Multiple Myeloma
4
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Lenalidomide
×
90 days
×
Clear all
No trials found.